Prosecution Insights
Last updated: October 25, 2026

Smirman Ip Law, Pllc

Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering

5 pending office actions • 5 clients • 5 examiners • 5 art units • 0 of 5 (0%) have an AI response strategy ready

Analysis

SMIRMAN IP LAW, PLLC has 5 pending office actions in Biotechnology & Pharmaceuticals. The profile records 618 career applications, an 82.45% resolved allowance rate, and an average of 3.01 office actions per allowance.

The historical data indicates a portfolio with a measurable allowance record and multiple examination exchanges associated with allowance. The small pending docket can be managed with focused review, while the broader figures provide context rather than a prediction for any particular application.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=618 apps, methodology: how we score firms)

82.4%
Allowance Rate
n=618
+0.62σ
Allowance Rate (norm)
n=618
3.0
OAs to Allowance
n=451
-0.31σ
OAs to Allow (norm)
n=451
1044 days
Time to Allowance
n=451
+13.6pp
Interview Lift
n=618
19.0%
RCE Rate
n=618
0.2%
Appeal Rate
n=618

Rejection Performance (% of received rejections ultimately overcome)

74.2%
§101 Overcome
n=97
81.1%
§102 Overcome
n=206
80.4%
§103 Overcome
n=336
81.2%
§112 Overcome
n=320

Specialization & Scale

G06Q, G06F, Y02E
Top CPC Subclasses
14%
Top-3 CPC Share
n=618
1
Practitioners
n=618
618.0
Apps / Practitioner
n=618

Portfolio Summary

5
Total Pending OAs
3
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (60%)
1
Medium (20%)
1
Easy (20%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (20%)
§112 only1 (20%)
Multi-statute (no §101)3 (60%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
40% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
20% of docket
2
Mechanical / Eng
40% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TROY, DANIEL J 1 57.1% +30.4%
GOLLAMUDI, NEERAJA 1 72.6% +40.0%
SCHMIDT, IZABELA MARIA 1 65.7% +42.7%
TURNER, BRIAN 1 83.4% +4.1%
LOVE, TREVOR M 1 43.1% +26.8%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18750711 MEDICAL FLUID CONNECTOR GOLLAMUDI, NEERAJA —
18578252 A SELF-EMULSIFYING DRUG DELIVERY FORMULATION WITH IMPROVED ORAL BIOAVAILABILITY OF LIPOPHILIC COMPOUND SCHMIDT, IZABELA MARIA —
18268141 A METHOD FOR FABRICATING SEMICONDUCTOR ARTICLES AND SYSTEM THEREOF TURNER, BRIAN —

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18865248 FALL-ARREST DEVICES TROY, DANIEL J —
18750711 MEDICAL FLUID CONNECTOR GOLLAMUDI, NEERAJA —
18578252 A SELF-EMULSIFYING DRUG DELIVERY FORMULATION WITH IMPROVED ORAL BIOAVAILABILITY OF LIPOPHILIC COMPOUND SCHMIDT, IZABELA MARIA —
17434422 SYNERGISTIC COMBINATION OF PHYTOACTIVES LOVE, TREVOR M —

Client Portfolio (5 clients)

Top Art Units

Art UnitApps
36341
37831
16211
28181
16111

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18865248 FALL-ARREST DEVICES International Safety Components Ltd. TROY, DANIEL J 3634 §112 Non-Final OA — Pending Nov 12, 2024
18750711 MEDICAL FLUID CONNECTOR Welford Manufacturing (M) Sdn Bhd GOLLAMUDI, NEERAJA 3783 §102§112 Non-Final OA — Pending Jun 21, 2024
18578252 A SELF-EMULSIFYING DRUG DELIVERY FORMULATION WITH IMPROVED ORAL BIOAVAILABILITY OF LIPOPHILIC COMPOUND Avantsar Sdn Bhd SCHMIDT, IZABELA MARIA 1621 §102§103 Final Rejection — Pending Jan 10, 2024
18268141 A METHOD FOR FABRICATING SEMICONDUCTOR ARTICLES AND SYSTEM THEREOF Inari Technology Sdn Bhd TURNER, BRIAN 2818 §103§112 Final Rejection — Pending Jun 16, 2023
17434422 SYNERGISTIC COMBINATION OF PHYTOACTIVES Shankaranarayanan Jeyakodi LOVE, TREVOR M 1611 §103 Non-Final OA — Pending Aug 27, 2021

Managing Smirman Ip Law, Pllc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Smirman Ip Law, Pllc's patent allowance rate?

82.5% of resolved applications prosecuted by Smirman Ip Law, Pllc were allowed, across 618 applications in USPTO records.

How many office actions does Smirman Ip Law, Pllc average before allowance?

3.01 office actions per allowed application on average.

How many pending office actions does Smirman Ip Law, Pllc have?

5 pending office actions as of October 2026, for 5 clients, before 5 examiners in 5 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month